- Home
- CRNT vs THRD Comparison
CRNT vs THRD Comparison
Compare CRNT & THRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNT
- THRD
- Stock Information
- Founded
- CRNT 1996
- THRD 2019
- Country
- CRNT Israel
- THRD United States
- Employees
- CRNT N/A
- THRD N/A
- Industry
- CRNT Radio And Television Broadcasting And Communications Equipment
- THRD Biotechnology: Pharmaceutical Preparations
- Sector
- CRNT Technology
- THRD Health Care
- Exchange
- CRNT Nasdaq
- THRD Nasdaq
- Market Cap
- CRNT 390.5M
- THRD 335.2M
- IPO Year
- CRNT 2000
- THRD 2022
- Fundamental
- Price
- CRNT $4.49
- THRD $5.79
- Analyst Decision
- CRNT Strong Buy
- THRD Strong Buy
- Analyst Count
- CRNT 4
- THRD 3
- Target Price
- CRNT $6.44
- THRD $20.33
- AVG Volume (30 Days)
- CRNT 2.1M
- THRD 255.8K
- Earning Date
- CRNT 02-18-2025
- THRD 11-07-2024
- Dividend Yield
- CRNT N/A
- THRD N/A
- EPS Growth
- CRNT N/A
- THRD N/A
- EPS
- CRNT 0.21
- THRD N/A
- Revenue
- CRNT $377,617,000.00
- THRD N/A
- Revenue This Year
- CRNT $15.29
- THRD N/A
- Revenue Next Year
- CRNT $5.78
- THRD N/A
- P/E Ratio
- CRNT $21.19
- THRD N/A
- Revenue Growth
- CRNT 13.62
- THRD N/A
- 52 Week Low
- CRNT $2.33
- THRD $5.60
- 52 Week High
- CRNT $5.73
- THRD $16.94
- Technical
- Relative Strength Index (RSI)
- CRNT 48.44
- THRD 21.25
- Support Level
- CRNT $4.43
- THRD $5.86
- Resistance Level
- CRNT $4.98
- THRD $11.78
- Average True Range (ATR)
- CRNT 0.36
- THRD 0.91
- MACD
- CRNT -0.09
- THRD -0.49
- Stochastic Oscillator
- CRNT 9.49
- THRD 3.11
About CRNT Ceragon Networks Ltd.
Ceragon Networks Ltd is a wireless transport company in terms of unit shipments and global distribution of its business, providing high-capacity wireless connectivity solutions to global markets across various industries, mainly wireless (mobile) networks service providers. Geographically the company generates the major revenue from India. The company also has presence in North America, Europe, Africa, Asia-Pacific and Middle East, and Latin America. The company's products include IP-50 Platform, IP-20 Platform, Pointlink.
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.